Načítá se...
Moderate to severe psoriasis treatment challenges through the era of biological drugs
Biological therapy has revolutionized moderate to severe psoriasis treatment. However, despite being more effective than conventional systemic treatments, some patients do not respond or lose response to biotechnological treatments or develop drug-antibodies, interfering with its safety and efficacy...
Uloženo v:
| Vydáno v: | An Bras Dermatol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Sociedade Brasileira de Dermatologia
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5674700/ https://ncbi.nlm.nih.gov/pubmed/29166504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/abd1806-4841.20175603 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|